necessity of retention samples for pilot BE study [Regulatives / Guidelines]

posted by nobody – 2019-11-26 11:11 (1168 d 18:40 ago) – Posting: # 20872
Views: 2,101

❝ My angle on this was related. FDA recently issued a PSG for Beclo/Calcipotriol introducing the need for a pilot trial.


This is this occult skin bleaching (vasocontrictor) test, here you don't "ship" any samples at all.

Ladies, these backup samples are for reproducing results in case the primary analysis is fishy. And to stop labs from making up studies and results completely (with mixed results on this part). I would keep this in mind when planning a trial.

If you are in doubt, start a controlled correspondence with the-one-not-to-be-named (aka USA-FDA-Trump-whatever...)

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
22,481 posts in 4,710 threads, 1,603 registered users;
32 visitors (0 registered, 32 guests [including 22 identified bots]).
Forum time: 05:51 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5